Drugs / EG-009A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04561180 | Mar 2022 → May 2023 | pneumonia | Evergreen Therapeutics, Inc. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EG-009A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04561180 ↗ |
| Route | Intramuscular | “Administered as an Intramuscular injection” NCT04561180 ↗ |